FDA Anti-Inflammatory Division Director Will Be Celebrex Investigator Simon
Celebrex clinical investigator Lee Simon, MD, will take over as director of FDA's Division of Anti-Inflammatory, Analgesic & Ophthalmic Drug Products Nov. 19.
Celebrex clinical investigator Lee Simon, MD, will take over as director of FDA's Division of Anti-Inflammatory, Analgesic & Ophthalmic Drug Products Nov. 19.